Rentokil Initial Analyst Price Targets - Benzinga

Rentokil Initial PLC

RTONYSE

Trade with Public

Trade with Public

$21.34

-0.025-0.12%

Ult. Agg.: Sep 22, 10:24 AM

Panoramica Notizie Previsioni utiliObiettivi di prezzoDati finanziari Sentiment Azionariato Dividendi Confronta Opzioni Rapporto azionario

Rentokil Initial Analyst Price Targets

Wall Street analyst price targets and consensus rating for Rentokil Initial (RTO).

Price Target Range — 2 Quarters

Analyst Consensus — 8 Analysts

6Buy

2Hold

Consensus RatingNeutral# Analysts8Avg. Consensus PT$32Upside to Avg. PT+50.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 7, 2026	Goldman Sachs	Suhasini Varanasi	Upgrade	Neutral→Buy	—
Mar 12, 2026	UBS	Nicole Manion	Upgrade	Neutral→Buy	—
Mar 10, 2026	Oppenheimer	Ian Zaffino	PT Raise	Outperform	$30→$35
Nov 21, 2025	JP Morgan	Jane Sparrow	Reinstates	Overweight	—
Oct 7, 2025	Bernstein	Will Kirkness	Upgrade	Underperform→Outperform	—
Sep 19, 2024	Redburn Atlantic	Oliver Davies	Downgrade	Buy→Neutral	—
Jul 1, 2024	UBS	—	Upgrade	Sell→Neutral	—
Mar 18, 2024	Exane BNP Paribas	—	Upgrade	Neutral→Outperform	—
Jan 24, 2024	B of A Securities	Simona Sarli	Downgrade	Buy→Neutral	$40→$29

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Upgrades Rentokil Initial to Buy

UBS analyst Nicole Manion upgrades Rentokil Initial (NYSE:RTO) from Neutral to Buy.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Rentokil Initial, Raises Price Target to $35

Oppenheimer analyst Ian Zaffino maintains Rentokil Initial (NYSE:RTO) with a Outperform and raises the price target from $30 to $35.

Benzinga Newsdesk

PRO
JP Morgan Reinstates Overweight on Rentokil Initial

JP Morgan analyst Jane Sparrow reinstates Rentokil Initial (NYSE:RTO) with a Overweight.

Benzinga Newsdesk

PRO
Bernstein Upgrades Rentokil Initial to Outperform

Bernstein analyst Will Kirkness upgrades Rentokil Initial (NYSE:RTO) from Underperform to Outperform.

Benzinga Newsdesk

PRO
Redburn Atlantic Downgrades Rentokil Initial to Neutral

Redburn Atlantic analyst Oliver Davies downgrades Rentokil Initial (NYSE:RTO) from Buy to Neutral.

Benzinga Newsdesk

PRO
UBS Upgrades Rentokil Initial to Neutral

UBS upgrades Rentokil Initial (NYSE:RTO) from Sell to Neutral.

Benzinga Newsdesk